AviGate ND QV4 lyophilisate for oculonasal suspension/use in drinking water for chickens
AviGate ND QV4 lyophilisate for oculonasal suspension/use in drinking water for chickens
Authorised
- Newcastle disease virus, strain QV4, Live
Product identification
Medicine name:
AviGate ND QV4 lyophilisate for oculonasal suspension/use in drinking water for chickens
Avigate ND QV4, Lyofilizát pro okulonazální suspenzi/pro podání v pitné vodě
Active substance:
- Newcastle disease virus, strain QV4, Live
Target species:
-
Chicken
Route of administration:
-
Oculonasal use
-
In drinking water use
Product details
Active substance and strength:
-
Newcastle disease virus, strain QV4, Live6.00/log 10 50% embryo infective dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
-
Oculonasal use
-
Chicken
-
All relevant tissues0day
-
-
-
In drinking water use
-
Chicken
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Package description:
- Carton box with 10 glass vials (type I) containing 1 000 doses, closed with a rubber stopper and sealed with an aluminium cap.
- Carton box with 10 glass vials (type I) containing 2 500 doses, closed with a rubber stopper and sealed with an aluminium cap.
- Carton box with 10 glass vials (type I) containing 5 000 doses, closed with a rubber stopper and sealed with an aluminium cap.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 8 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet AD
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 97/012/26-C
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0435/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Czechia
-
Greece
-
Italy
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 9/02/2026
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 9/02/2026
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 9/02/2026